Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer

Featuring perspectives from Dr Bob Li, including the following topics: •      Evolution of targeted therapy for HER2-altered non-small cell lung cancer (NSCLC) (0:00) •      Incidence and management of HER2 amplifications and mutations in NSCLC (10:45) •      Role of ErbB/HER protein family biology in lung cancer (19:03) •      Current and emerging roles of antibody-drug conjugates in lung cancer (33:43) •      Considerations for clinical trial participation and improving access to care for patients with cancer (55:08) •      Management of trastuzumab deruxtecan-associated interstitial lung disease (1:03:18) •      Future of HER2-targeted therapy in lung cancer and beyond (1:14:39) CME information and select publications